Phase 3 Hypertension Diabetes Trial, Seoul
Summary
A Phase 3 clinical trial evaluating treatments for hypertension and diabetes has been registered on ClinicalTrials.gov under identifier NCT07552389. The trial is being conducted in Seoul, South Korea. ClinicalTrials.gov is maintained by the National Institutes of Health (NIH) National Library of Medicine as a publicly accessible registry of clinical studies.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 21 changes logged to date.
What changed
A new clinical trial registration entry for a Phase 3 study investigating hypertension and diabetes was added to the ClinicalTrials.gov registry operated by the NIH. The trial is identified by NCT07552389 and listed as taking place in Seoul, South Korea. ClinicalTrials.gov serves as the primary public repository for clinical study information in the United States under FDAAA 2007 requirements.
Healthcare institutions, clinical investigators, and trial sponsors conducting or planning international Phase 3 studies should ensure their trials are registered on ClinicalTrials.gov where required. The registry entry provides public access to study purpose, design, eligibility criteria, and locations for this hypertension and diabetes study.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.